We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Association Between Uterine Artery Notch and First Trimester Bleeding

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01069406
Recruitment Status : Completed
First Posted : February 17, 2010
Last Update Posted : May 20, 2015
Sponsor:
Information provided by (Responsible Party):
Gali Pariente, Soroka University Medical Center

Brief Summary:

The purpose of the present study is to evaluate the occurrence of first trimester bleeding among patients with abnormal uterine artery Doppler.

A prospective study is designed and two groups will be studied; patients with abnormal uterine artery Doppler at second trimester (study group) and patient with normal uterine artery Doppler at second trimester (control group).The patients will be asked, as part of the routine history taken before the US about having first trimester bleeding during the current pregnancy.


Condition or disease
Uterine Artery Notch First Trimester Bleeding

Detailed Description:

The purpose of the present study is to evaluate the occurrence of first trimester bleeding among patients with abnormal uterine artery Doppler.

A prospective study is designed and two groups will be studied; patients with abnormal uterine artery Doppler at second trimester (study group) and patient with normal uterine artery Doppler at second trimester (control group). Both the study group and the control group represent high risk pregnant patients and the Doppler flows are done as part of the patient's predictive risk for placental associated abnormalities. The patients will be asked, as part of the routine history taken before the US about having first trimester bleeding during the current pregnancy.


Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Association Between Uterine Artery Notch and First Trimester Bleeding
Study Start Date : March 2010
Primary Completion Date : May 2012
Study Completion Date : May 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding
U.S. FDA Resources

Group/Cohort
presence of uterine artery notch
patients with uterine artery notch during the 2nd and 3rd trimester




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with abnormal uterine artery Doppler at second trimester. pregnant women with eather: elevated HCG and/or aFP at triple test, patients with history of pre eclampsia, IUGR, APD, and patients with thrombophilia.
Criteria

Inclusion Criteria:

  • Patients with abnormal uterine artery Doppler at second trimester

Exclusion Criteria:

  • Multi fetal pregnancies
  • Patients without known gestational age (according to last month period or first trimester ultrasound
  • Pregnancies with congenital structural or chromosomal anomalies
  • Lack of prenatal care

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01069406


Locations
Israel
Us unit
Soroka medical center, Beer sheva, Israel
Sponsors and Collaborators
Soroka University Medical Center

Responsible Party: Gali Pariente, Dr, Soroka University Medical Center
ClinicalTrials.gov Identifier: NCT01069406     History of Changes
Other Study ID Numbers: sor493710CTIL
First Posted: February 17, 2010    Key Record Dates
Last Update Posted: May 20, 2015
Last Verified: May 2015

Keywords provided by Gali Pariente, Soroka University Medical Center:
notch
uterine
first
bleeding

Additional relevant MeSH terms:
Hemorrhage
Pathologic Processes